Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | ARG1 | P05089 | 1/20 | 0.31 |
| ▸ | ARG2 | P78540 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3543647 | 0.85 | GABRR1 (0.33) | ALDH1A1CYP1A2MEN1THRBKMT2A | |
| SCHEMBL23451474 | 0.85 | — | — | |
| SCHEMBL29184106 | 0.85 | ALDH1A1 (0.33) | ALDH1A1CYP1A2MEN1THRBKMT2A | |
| SCHEMBL10208075 | 0.82 | — | — | |
| SCHEMBL5445954 | 0.82 | CA2 (0.33) | ARG1ARG2 | |
| SCHEMBL9064172 | 0.82 | — | — | |
| SCHEMBL2510899 | 0.81 | ALDH1A1 (0.36) | ALDH1A1CYP1A2FFAR3MEN1THRB | |
| SCHEMBL3700078 | 0.81 | ALDH1A1 (0.36) | ALDH1A1CYP1A2FFAR3MEN1THRB | |
| SCHEMBL3550650 | 0.80 | ARG1 (0.31) | ARG1ARG2 | |
| SCHEMBL11589986 | 0.80 | CES2 (0.37) | ALDH1A1MEN1KMT2ATSHRARG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2693896-B1 | FRUITY FLAVORED COCOA PRODUCTS AND PROCESSES FOR PRODUCING SUCH COCOA PRODUCTS | OLAM INTERNATIONAL LTD (SG) | 2018-09-12 | — | — | EP | claimed |
| US-20080175800-A1 | USE OF SPECIFIC MENTHYL 3-OXOCARBOXYLIC ACID ESTERS AS PHYSIOLOGICALLY ACTIVE COOLING SUBSTANCES | SYMRISE GMBH & CO. KG (DE) | 2008-07-24 | — | — | US | claimed |
| EP-1276562-B1 | DMC COMPLEX CATALYST AND PROCESS FOR ITS PREPARATION | SHELL INT RESEARCH (NL) | 2003-09-17 | — | — | EP | claimed |
| CN-109952360-B | Quantum dot dispersion, self-luminous photosensitive resin composition, color filter manufactured using the same, and image display device | 东友精细化工有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-106602013-B | Preparation method of sulfur-activated carbon/graphene composite material | 中国科学院山西煤炭化学研究所 | 2020-11-27 | — | — | CN | disclosed |
| US-9663597-B2 | Acrylic polyol resins compositions | HEXICON INC. (US) | 2017-05-30 | — | — | US | disclosed |
| US-9663597-B2 | Acrylic polyol resins compositions | HEXICON INC. (US) | 2017-05-30 | — | — | US | disclosed |
| US-20140316030-A1 | GLYCIDYL ESTERS OF ALPHA, ALPHA BRANCHED NEONONANOIC ACIDS, SYNTHESIS AND USES | MOMENTIVE SPECIALTY CHEMICALS INC. (US) | 2014-10-23 | — | — | US | disclosed |
| US-20140316030-A1 | GLYCIDYL ESTERS OF ALPHA, ALPHA BRANCHED NEONONANOIC ACIDS, SYNTHESIS AND USES | MOMENTIVE SPECIALTY CHEMICALS INC. (US) | 2014-10-23 | — | — | US | disclosed |
| US-20140295193-A1 | POLYESTER POLYOL RESINS COMPOSITIONS | MOMENTIVE SPECIALTY CHEMICALS INC. (US) | 2014-10-02 | — | — | US | disclosed |
| US-20140295193-A1 | POLYESTER POLYOL RESINS COMPOSITIONS | MOMENTIVE SPECIALTY CHEMICALS INC. (US) | 2014-10-02 | — | — | US | disclosed |
| EP-1033360-B1 | Process for preparing vinylesters from butene oligomers | OXENO OLEFINCHEMIE GMBH (DE) | 2003-09-17 | — | — | EP | disclosed |
| US-6500979-B1 | CATALYST IS PRESENT IN THE CONTINUOUS PHASE AND AT LEAST ONE STARTING MATERIAL IS PRESENT IN A DISPERSED PHASE; INTER-MEDIATES FOR POLYMERS AND ADHESIVES | OXENO OLEFINCHEMIE GMBH (DE) | 2002-12-31 | — | — | US | disclosed |
| US-6433242-B1 | SEPARATION OF ISOMER MIXTURE USING ZEOLITE CATALYST | OXENO OLEFINCHEMIE GMBH (DE) | 2002-08-13 | — | — | US | disclosed |
| US-6281372-B1 | OLIGOMERIZING BUTENE WITH FIXED BED NICKEL CATALYST; SEPARATION; CARBOXYLATION; ESTERIFICATION | OXENO OLEFINCHEMIE GMBH (DE) | 2001-08-28 | — | — | US | disclosed |
| EP-1057525-A2 | Process to perform catalysed multiphase reactions, especially vinylations of carboxylic acids | Oxeno Olefinchemie GmbH (DE) | 2000-12-06 | — | — | EP | disclosed |
| CN-1269352-A | Method for preparing vinyl ester using butene low polymers | OXNOLERTIN CHEMICAL CO LTD (DE) | 2000-10-11 | — | — | CN | disclosed |
| CN-1266835-A | Process for fractionation of dibutene | OXENO OLEFINCHEMIE GMBH (DE) | 2000-09-20 | — | — | CN | disclosed |
| EP-1033360-A1 | Process for preparing vinylesters from butene oligomers | Oxeno Olefinchemie GmbH (DE) | 2000-09-06 | — | — | EP | disclosed |
| EP-1029839-A1 | Process for fractionating dibutene | Oxeno Olefinchemie GmbH (DE) | 2000-08-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080175800-A1 | USE OF SPECIFIC MENTHYL 3-OXOCARBOXYLIC ACID ESTERS AS PHYSIOLOGICALLY ACTIVE COOLING SUBSTANCES | ECI1, OTC, MDH2 | ALDH1A1 748/4885CYP1A2 823/4885FFAR3 973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.